Abstract
Muscular dystrophy is a general term for a heterogenous group of inherited, progressive diseases that primarily affect skeletal muscle to cause muscle weakness. The muscles involved, the age of onset, and the rate of progression vary considerably in the different diseases. In some of the muscular dystrophies, ....
| Original language | English |
|---|---|
| Title of host publication | xPharm: The Comprehensive Pharmacology Reference |
| Publisher | Elsevier Inc. |
| Pages | 1-6 |
| Number of pages | 6 |
| ISBN (Print) | 9780080552323 |
| DOIs | |
| State | Published - 2011 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology, Toxicology and Pharmaceutics(all)
Cite this
Muscular dystrophy. / Kincaid, Anthony.
xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., 2011. p. 1-6.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Muscular dystrophy
AU - Kincaid, Anthony
PY - 2011
Y1 - 2011
N2 - Muscular dystrophy is a general term for a heterogenous group of inherited, progressive diseases that primarily affect skeletal muscle to cause muscle weakness. The muscles involved, the age of onset, and the rate of progression vary considerably in the different diseases. In some of the muscular dystrophies, ....
AB - Muscular dystrophy is a general term for a heterogenous group of inherited, progressive diseases that primarily affect skeletal muscle to cause muscle weakness. The muscles involved, the age of onset, and the rate of progression vary considerably in the different diseases. In some of the muscular dystrophies, ....
UR - http://www.scopus.com/inward/record.url?scp=84883988404&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883988404&partnerID=8YFLogxK
U2 - 10.1016/B978-008055232-3.60685-3
DO - 10.1016/B978-008055232-3.60685-3
M3 - Chapter
SN - 9780080552323
SP - 1
EP - 6
BT - xPharm: The Comprehensive Pharmacology Reference
PB - Elsevier Inc.
ER -